Maes, Michael

Leukocytosis, monocytosis and neutrophilia: Hallmarks of severe depression

Maes, M., Van Der Planken, M., Stevens, W. J., Peeters, D., DeClerck, L. S., Bridts, C. H., Schotte, C., & Cosyns, P. (1992) · Journal of Psychiatric Research

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 186

The Glutathione System in Parkinson’s Disease and Its Progression

Bjørklund, G., Peana, M., Maes, M., Dadar, M., & Severin, B. (2021) · Neuroscience & Biobehavioral Reviews

Parkinson's Disease Mechanisms and TreatmentsRedox biology and oxidative stress

Cited by 186

Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients

Maes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Tryptophan and brain disordersCardiac Health and Mental Health

Cited by 169

A model of the mitochondrial basis of bipolar disorder

Morris, G., Walder, K., McGee, S. L., Dean, O. M., Tye, S. J., Maes, M., & Berk, M. (2017) · Neuroscience & Biobehavioral Reviews

Bipolar Disorder and TreatmentMitochondrial Function and Pathology

Cited by 162

Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics

Maes, M. (2000) · European Neuropsychopharmacology

Tryptophan and brain disordersSchizophrenia research and treatment

Cited by 156

Exercising the worry away: how inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours

Moylan, S., Eyre, H. A., Maes, M., Baune, B. T., Jacka, F. N., & Berk, M. (2013) · Neuroscience & Biobehavioral Reviews

Exercise and Physiological ResponsesTryptophan and brain disorders

Cited by 155

Food addiction: Prevalence, psychopathological correlates and associations with quality of life in a large sample

Nunes-Neto, P. R., Köhler, C. A., Schuch, F. B., Solmi, M., Quevedo, J., Maes, M., Murru, A., Vieta, E., McIntyre, R. S., McElroy, S. L., et al. (2018) · Journal of Psychiatric Research

Eating Disorders and BehaviorsNutrition, Health and Food Behavior

Cited by 150

Nutrient intakes and the common mental disorders in women

Jacka, F. N., Maes, M., Pasco, J. A., Williams, L. J., & Berk, M. (2012) · Journal of Affective Disorders

Nutritional Studies and DietMental Health Treatment and Access

Cited by 149

Higher α1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: Further evidence for the existence of an inflammatory response during that illness

Maes, M. (1992) · Journal of Affective Disorders

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 147

The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder

Gałecki, P., Gałecka, E., Maes, M., Chamielec, M., Orzechowska, A., Bobińska, K., Lewiński, A., & Szemraj, J. (2012) · Journal of Affective Disorders

Tryptophan and brain disordersTreatment of Major Depression

Cited by 141

Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?

Maes, M., Anderson, G., Kubera, M., & Berk, M. (2014) · Expert Opinion on Therapeutic Targets

Tryptophan and brain disordersTreatment of Major Depression

Cited by 140

Stimulatory effect of antidepressants on the production of IL-6

Kubera, M., Kenis, G., Bosmans, E., Kajta, M., Basta-Kaim, A., Scharpe, S., Budziszewska, B., & Maes, M. (2004) · International Immunopharmacology

Tryptophan and brain disordersTreatment of Major Depression

Cited by 126

Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass

Davis, J., Maes, M., Andreazza, A., McGrath, J. J., Tye, S. J., & Berk, M. (2015) · Molecular Psychiatry

Dementia and Cognitive Impairment ResearchMental Health and Psychiatry

Cited by 123

Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges

Davinelli, S., Maes, M., Corbi, G., Zarrelli, A., Willcox, D. C., & Scapagnini, G. (2016) · Immunity & Ageing

Phytochemicals and Antioxidant ActivitiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 122

Neurodevelopmental pathways in bipolar disorder

Kloiber, S., Rosenblat, J. D., Husain, M. I., Ortiz, A., Berk, M., Quevedo, J., Vieta, E., Maes, M., Birmaher, B., Soares, J. C., et al. (2020) · Neuroscience & Biobehavioral Reviews

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 122

In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress.

Maes, M., Christophe, A., Bosmans, E., Lin, A., & Neels, H. (2000) · Biological Psychiatry

Fatty Acid Research and HealthTryptophan and brain disorders

Cited by 118

A neuro-immune model of myalgic encephalomyelitis/chronic fatigue syndrome

Morris, G., & Maes, M. (2013) · Metabolic Brain Disease

Fibromyalgia and Chronic Fatigue Syndrome ResearchLong-Term Effects of COVID-19

Cited by 117

The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system

Maes, M., Ombelet, W., De Jongh, Kenis, G., & Bosmans, E. (2001) · Journal of Affective Disorders

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 116

Increased autoimmune activity against 5-HT: A key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression

Maes, M., Ringel, K., Kubera, M., Berk, M., & Rybakowski, J. (2012) · Journal of Affective Disorders

Tryptophan and brain disordersTreatment of Major Depression

Cited by 116

Inflammation and nitro-oxidative stress in current suicidal attempts and current suicidal ideation: a systematic review and meta-analysis

Vasupanrajit, A., Jirakran, K., Tunvirachaisakul, C., Solmi, M., & Maes, M. (2022) · Molecular Psychiatry

Suicide and Self-Harm StudiesTryptophan and brain disorders

Cited by 109

Melatonin: An overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects

Anderson, G., & Maes, M. (2012) · Metabolic Brain Disease

Schizophrenia research and treatmentCircadian rhythm and melatonin

Cited by 105

Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts

Sowa-Kućma, M., Styczeń, K., Siwek, M., Misztak, P., Nowak, R. J., Dudek, D., Rybakowski, J. K., Nowak, G., & Maes, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Tryptophan and brain disordersBipolar Disorder and Treatment

Cited by 104

Cognitive Impairment in Euthymic Pediatric Bipolar Disorder: A Systematic Review and Meta-Analysis

Elias, L. R., Miskowiak, K. W., Vale, A. M. O., Köhler, C. A., Kjærstad, H. L., Stubbs, B., Kessing, L. V., Vieta, E., Maes, M., Goldstein, B. I., et al. (2017) · Journal of the American Academy of Child & Adolescent Psychiatry

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 104

Gut Permeability and Microbiota in Parkinson’s Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways

Anderson, G., Seo, M., Berk, M., Carvalho, A., & Maes, M. (2016) · Current Pharmaceutical Design

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 103